Vetnostrum Animal Health Co., Ltd (6936) Fair Value & Analysis
Consumer Defensive · TW · Market cap 2.4B TWD (≈ $75.9M)
What is Vetnostrum Animal Health Co., Ltd really worth?
A solid business, currently priced close to our fair value of 35.10 TWD.
Strengths
Risks
For context
Fair value as of: Aug 28, 2026
From 26 valuation models · updated 7 days ago
Share price +3.3% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- The price sits in the lower half of our model range, the side with the larger margin of safety.
- The data supports the verdict: every model runs on fully documented inputs.
Price vs Fair Value (3 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 28, 2026.
How to read this chart
41‑month range 29.83 TWD – 45.72 TWD · fair‑value band 25.99 TWD – 44.22 TWD · the 32.80 TWD price screens below the 35.10 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 28, 2026.
Analysis
Vetnostrum Animal Health Co., Ltd (6936) currently trades at 32.80 TWD, while our model-based Fair Value estimate is 35.10 TWD, implying the stock looks roughly 6.6% fairly valued today. The Quality Score stands at 68/100 (solid quality), in the Consumer Defensive sector. Bull case: the DCF Models group reads highest at a median of 47.09 TWD per share, and 15 of the 26 models we run sit above the 32.80 TWD price. Bear case: the Earnings-Based group reads lowest at 11.72 TWD, and 11 of the 26 models stay below the price. Evidence for this calculation is high.
Over the trailing twelve months, Vetnostrum Animal Health Co., Ltd generated revenue of 1.4B TWD at a net margin of 9.5%. Revenue grew 8.1% year over year. It earns a return on equity of 10.7%. Net debt stands at 98.4M TWD. Fundamentals as of Aug 28, 2026
Our scenario range runs from 25.99 TWD (bear case) to 44.22 TWD (bull case); at 32.80 TWD, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 26% below its 52-week high and 5% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at −19% fair-value upside, at 7%, 6936 screens cheaper than that median.
Fair Value models
This estimate rests on fiscal year 2025 figures, and about 8 months have passed since. In that time the company retained roughly 0.2098 TWD per share, which is 0.6 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 26 models by family
Widest divergence: DCF Models (47.09 TWD) versus Earnings-Based (11.72 TWD). Highest evidence: FCF DCF (77).
Notify me when 6936 reaches fair value
Put 6936 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 28, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 68 · Market factors (momentum, volatility) 49
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Vetnostrum Animal Health Co., Ltd. engages in the import, manufacture, and sale of animal medicines, health food, feed additives, and feed.
Full company description
Vetnostrum Animal Health Co., Ltd. engages in the import, manufacture, and sale of animal medicines, health food, feed additives, and feed. It offers antibiotics, hormonal preparations, topical disinfectants, and drugs for anti-inflammatory, deworming, anti-fungal, antiprotozoal, etc; vitamins, minerals, and amino acids for regular supplementary; and non-medicated feed additives for swine, cattle and sheep, poultry, pet, and aquatic animals. The company was founded in 2012 and is based in Hsinchu City, Taiwan. Vetnostrum Animal Health Co., Ltd. operates as a subsidiary of YungShin Global Holding Corporation.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Vetnostrum Animal Health Co., Ltd reported revenue of 1.4B TWD in FY2025 versus 1.2B TWD in FY2021, a compound +4.7%/yr. Reported net income was 129M TWD in FY2025, compounding +4.1%/yr from FY2021.
Watch 6936: get an alert when its fair value changes →
Peer Group
Farm Products · 293 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Farm Products median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Aug 28, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Archer-Daniels-Midland Company ADM | $81.54 | $38.02 | −53% |
| Muyuan Foods Group 002714 | ¥40.15 | ¥47.42 | +18% |
| Bunge Global SA BG | $111.57 | $56.19 | −50% |
| Tyson Foods, Inc TSN | $55.40 | $28.60 | −48% |
| Wens Foodstuff Group 300498 | ¥13.80 | ¥11.18 | −19% |
| Mowi ASA MOWI | kr 201.80 | kr 256.14 | +27% |
| Fujian Wanchen Food Group 300972 | ¥201.06 | ¥143.09 | −29% |
| United Plantations Berhad 2089 | 32.60 MYR | 23.34 MYR | −28% |
| Charoen Pokphand Foods Public Company CPF | 23.40 THB | 43.24 THB | +85% |
| PT Charoen Pokphand Indonesia Tbk, CPIN | 2,960 IDR | 6,818 IDR | +130% |
Compare Vetnostrum Animal Health Co., Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Vetnostrum Animal Health Co., Ltd (6936) overvalued or undervalued?
What is the fair value of 6936?
What is the quality score of 6936?
What is the revenue of Vetnostrum Animal Health Co., Ltd (6936)?
What is the net profit margin of 6936?
Does Vetnostrum Animal Health Co., Ltd pay a dividend?
Watch Vetnostrum Animal Health Co., Ltd in the live analysis
One click puts Vetnostrum Animal Health Co., Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.